MULTIPARAMETRIC TUMOR-MARKER ANALYSES (CA 19-9, CEA, UROKINASE-TYPE ANTIGEN) IN PLASMA OF PATIENTS WITH COLORECTAL-CANCER OR CROHNS-DISEASE

被引：0
|
作者：
HUBER, K
SEDLMAYER, A
KIRCHHEIMER, JC
RIMPFL, T
BINDER, BR
机构：
[1] VIENNA UNIV, DEPT CLIN EXPTL PHYSIOL, A-1090 VIENNA, AUSTRIA
[2] VIENNA UNIV, DEPT CARDIOL, A-1090 VIENNA, AUSTRIA
[3] VIENNA UNIV, DEPT GASTROENTEROL 2, A-1090 VIENNA, AUSTRIA
来源：
BLUT | 1988年 / 57卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：273 / 273
页数：1
相关论文
共 50 条
  • [11] THE CENTOCOR CA 19-9TM ASSAY AS A TUMOR-MARKER SYSTEM FOR COLORECTAL-CANCER
    BEGENT, RHJ
    DASS, S
    SMITH, A
    CHESTER, KA
    BRITISH JOURNAL OF CANCER, 1983, 47 (04) : 557 - 557
  • [12] PREDICTIVE VALUE OF TUMORAL MARKERS (CEA AND CA 19-9) IN COLORECTAL-CANCER
    DESAIVE, C
    SERVAIS, R
    COLLETTE, J
    DENIS, D
    REGINSTER, JY
    FRANCHIMONT, P
    ACTA GASTRO-ENTEROLOGICA BELGICA, 1987, 50 (01): : 65 - 78
  • [13] Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer
    László Herszényi
    Fabio Farinati
    Romilda Cardin
    Gábor István
    László D Molnár
    István Hritz
    Massimo De Paoli
    Mario Plebani
    Zsolt Tulassay
    BMC Cancer, 8
  • [14] Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer
    Herszenyi, Laszlo
    Farinati, Fabio
    Cardin, Romilda
    Istvan, Gabor
    Molnar, Laszlo D.
    Hritz, Istvan
    De Paoli, Massimo
    Plebani, Mario
    Tulassay, Zsolt
    BMC CANCER, 2008, 8 (1)
  • [15] ASSESSMENT OF A SERUM TUMOR-MARKER FOR CARCINOMA OF THE PANCREAS - THE CARBOHYDRATE ANTIGEN CA 19-9
    VINCENT, D
    VENOT, J
    CATANZANO, G
    CLEMENT, MN
    PIQUET, MF
    VEYRIRAS, E
    BECK, C
    ANNALES DE MEDECINE INTERNE, 1985, 136 (02): : 142 - 144
  • [16] EVALUATION OF CA 19-9 AS A SERUM TUMOR-MARKER IN PANCREATIC-CANCER
    HAGLUND, C
    ROBERTS, PJ
    KUUSELA, P
    SCHEININ, TM
    MAKELA, O
    JALANKO, H
    BRITISH JOURNAL OF CANCER, 1986, 53 (02) : 197 - 202
  • [17] MULTIPARAMETRIC TUMOR-MARKER (CA-19-9, CEA, AFP, POA) ANALYSES OF PANCREATIC JUICES AND SERA IN PANCREATIC DISEASES
    SCHMIEGEL, WH
    EBERL, W
    KREIKER, C
    KALTHOFF, H
    BUTZOW, GH
    JESSEN, K
    KLAPDOR, R
    SOEHENDRA, N
    WARGENAU, M
    CLASSEN, M
    GRETEN, H
    THIELE, HG
    HEPATO-GASTROENTEROLOGY, 1985, 32 (03) : 141 - 145
  • [18] TUMOR-MARKER ANTIGEN CA125 IN PANCREATIC-CANCER - A COMPARISON WITH CA19-9 AND CEA
    HAGLUND, C
    BRITISH JOURNAL OF CANCER, 1986, 54 (06) : 897 - 901
  • [19] THE ROLE OF CEA, TPA AND CA 19-9 IN THE EARLY DETECTION OF RECURRENT COLORECTAL-CANCER
    BARILLARI, P
    RAMACCIATO, G
    DEANGELIS, R
    GOZZO, P
    AURELLO, P
    INDINNIMEO, M
    VALABREGA, S
    DANGELO, F
    FEGIZ, G
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 1989, 4 (04) : 230 - 233
  • [20] CA50 - A USEFUL TUMOR-MARKER IN MONITORING PATIENTS WITH COLORECTAL-CANCER
    PERSSON, BE
    HOLMGREN, J
    BRITISH JOURNAL OF CANCER, 1987, 56 (04) : 521 - 522
12345